概述
                - 
                        货号 PAD12601 
- 
                                宿主 Rabbit
- 
                                同种型 IgG
- 
                                克隆类型 Polyclonal
- 
                                免疫原 Ranibizumab
- 
                                经测试应用 ELISA: 1:4000-1:8000
- 
                                靶标 Rabbit polyclonal to Lucentis.
- 
                                特异性 The product is specific for Ranibizumab. This antibody serves as an excellent positive control for Ranibizumab immunogenicity (ADA) assays.
- 
                                浓度 0.5 mg/ml
- 
                                纯化方式 Purified by antigen affinity column.
- 
                                Accession号 CAS: 347396-82-1
- 
                                应用 ELISA
- 
                                状态 Liquid
- 
                                保存溶液 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
- 
                                稳定性和存储 The product can be stored for 2 - 3 weeks at 2 to 8°C or for up to 12 months at -20°C. Avoid repeated freezing and thawing cycles.
- 
                                背景 Ranibizumab with trade name Lucentis, is an FDA-approved drug for the treatment of patients with neovascular (Wet) age-related macular degeneration (AMD) and macular edema following retinal vein occlusion (RVO). It is a recombinant humanized IgG1 kappa isotype monoclonal antibody fragment. Ranibizumab binds to vascular endothelial growth factor A (VEGF-A) and blocks its activity. Antibodysystem Anti-Ranibizumab Antibody, pAb, Rabbit is produced from sera of a rabbit immunized with Ranibizumab.
图片
                参考文献
                评价
                








 
                 
            